ESC Premium Access


Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Congress Presentation

6 more presentations in this session

Impact of mineralocorticoid receptor antagonists on sudden cardiac death in patients with heart failure and left ventricular systolic dysfunction: a meta-analysis of three randomized controlled trials

Speaker: Doctor F. Rossello (London, GB)


Right ventricular dysfunction in patients with reduced and mid-range ejection fraction: an echocardiographic study on the biventricular dysfunction in heart failure patients.

Speaker: Doctor M. Squillace (Milan, IT)


The impact of serum concentration guided digoxin therapy on mortality: a long-term follow-up, propensity-matched cohort study

Speaker: Doctor B. Muk (Budapest, HU)


Guideline-recommended medication including mineralocorticoid-receptor antagonists is associated with better long-term outcomes in octogenarian patients with acute heart failure.

Speaker: Doctor T. Abe (Tokyo, JP)


Effectiveness of the pharmacist-involved multidisciplinary management of heart failure to improve readmission and mortality rates: systematic review and meta-analysis of randomized controlled trials

Speaker: Mr D. Parajuli (Renmark, AU)


Access the full session

Strategies to optimize established heart failure therapies

Speakers: Doctor F. Rossello, Doctor M. Squillace, Doctor B. Muk, Doctor T. Abe, Mr D. Parajuli

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb